Comparing two methods of giving the drug propofol for making the patient sleep

Not Applicable

• Conditions: Health Condition 1: C509- Malignant neoplasm of breast of unspecified site

• Registration Number: CTRI/2019/11/022076
• Lead Sponsor: Rajiv Gandhi Cancer Institute and Research Centre

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 24 November 2021

Recruitment & Eligibility

• Status: ot Yet Recruiting
• Sex: Not specified
• Target Recruitment: 0

Inclusion Criteria

Weight 40-80kg

ASA physical status I and II

Patients undergoing breast cancer surgery

Exclusion Criteria

Patients who do not give consent

Allergy to propofol

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Volume of propofol in millilitre given by iTIVA TCI smartphone applicationTimepoint: 3min,10min,25min,45min,90min as per the Schneider pharmacokinetic model

Secondary Outcome Measures

Name	Time	Method
Heart rateTimepoint: 3min,10min,25min,45min,90min as per the Schneider pharmacokinetic model;Mean arterial pressureTimepoint: 3min,10min,25min,45min,90min as per the Schneider pharmacokinetic model;Volume of propofol in millilitre given by Injectomat Agilia conventional TCI pumpTimepoint: 3min,10min,25min,45min,90min as per the Schneider pharmacokinetic model